Role of esophageal stents in the nutrition support of patients with esophageal malignancy

Nutrition in Clinical Practice

Volumn 25, Issue 3, 2010, Pages 244-249

  Bower, Matthew ^a   Jones, Whitney ^a   Vessels, Ben ^a   Scoggins, Charles ^a   Martin, Robert ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

esophageal neoplasms; esophageal stenosis; esophageal stricture; nutrition therapy; stents

Indexed keywords

ANALGESIC AGENT; ANTINEOPLASTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; MORPHINE; NITINOL; OMEGA 3 FATTY ACID;

BARE METAL STENT; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIET SUPPLEMENTATION; DIET THERAPY; DRUG DELIVERY SYSTEM; DYSPHAGIA; ENDOSCOPY; ESOPHAGITIS; ESOPHAGORESPIRATORY FISTULA; ESOPHAGUS CANCER; ESOPHAGUS FISTULA; ESOPHAGUS PERFORATION; ESOPHAGUS RESECTION; ESOPHAGUS SPASM; ESOPHAGUS STENT; FLUOROSCOPY; HUMAN; IN-STENT RESTENOSIS; INTESTINE OBSTRUCTION; MALNUTRITION; NUTRITIONAL SUPPORT; PALLIATIVE THERAPY; PATIENT COUNSELING; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; QUALITY OF LIFE; REVIEW; SELF EXPANDING METAL STENT; STENT; THORAX PAIN; TREATMENT OUTCOME;

DEGLUTITION DISORDERS; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; ESOPHAGUS; HUMANS; NUTRITIONAL SUPPORT; PALLIATIVE CARE; STENTS;

EID: 77953996519     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884533610368710     Document Type: Review

References (50)

1. Hashemi N., Loren D., DiMarino AJ, Cohen S. Presentation and prognosis of esophageal adenocarcinoma in patients below age 50. Dig Dis Sci. 2009 ; 54: 1708-1712.
2. Bozzetti F. Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer. 2009 ; 17: 279-284.
3. Cancer Facts & Figures 2009. Atlanta, GA: American Cancer Society ; 2009.
4. Ra J., Paulson EC, Kucharczuk J., et al. Postoperative mortality after esophagectomy for cancer: development of a preoperative risk prediction model. Ann Surg Oncol. 2008 ; 15: 1577-1584.
5. Kohn GP, Galanko JA, Meyers MO, Feins RH, Farrell TM National trends in esophageal surgery-are outcomes as good as we believe? J Gastrointest Surg. 2009 ; 13: 1900-1910.
6. Herskovic A., Martz K., al- Sarraf M., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992 ; 326: 1593-1598.
7. Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002 ; 20: 1167-1174.
8. ODonnell CA, Fullarton GM, Watt E., Lennon K., Murray GD, Moss JG Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer. Br J Surg. 2002 ; 89: 985-992.
9. Urschel JD, Cockburn JS, Foote AV Palliation of oesophageal cancer-endoscopic intubation and laser therapy. Postgrad Med J. 1991 ; 67: 414-416.
10. Vakil N., Morris AI, Marcon N., et al. A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol. 2001 ; 96: 1791-1796.
11. Mayoral W., Fleischer D., Salcedo J., Roy P., Al- Kawas F., Benjamin S. Nonmalignant obstruction is a common problem with metal stents in the treatment of esophageal cancer. Gastrointest Endosc. 2000 ; 51: 556-559.
12. Elphick DA, Smith BA, Bagshaw J., Riley SA Self-expanding metal stents in the palliation of malignant dysphagia: outcome analysis in 100 consecutive patients. Dis Esophagus. 2005 ; 18: 93-95.
13. Wenger U., Johnsson E., Arnelo U., Lundell L., Lagergren J. An antireflux stent versus conventional stents for palliation of distal esophageal or cardia cancer: a randomized clinical study. Surg Endosc. 2006 ; 20: 1675-1680.
14. Shim CS, Jung IS, Cheon YK, et al. Management of malignant stricture of the esophagogastric junction with a newly designed self-expanding metal stent with an antireflux mechanism. Endoscopy. 2005 ; 37: 335-339.
15. Laasch HU, Marriott A., Wilbraham L., Tunnah S., England RE, Martin DF Effectiveness of open versus antireflux stents for palliation of distal esophageal carcinoma and prevention of symptomatic gastroesophageal reflux. Radiology. 2002 ; 225: 359-365.
16. Knyrim K., Wagner HJ, Bethge N., Keymling M., Vakil N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med. 1993 ; 329: 1302-1307.
17. Madhusudhan C., Saluja SS, Pal S., et al. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life. Dis Esophagus. 2009 ; 22: 331-336.
18. Conio M., Repici A., Battaglia G., et al. A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol. 2007 ; 102: 2667-2677.
19. Siersema PD, Hop WC, van Blankenstein M., et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc. 2001 ; 54: 145-153.
20. Selinger CP, Ellul P., Smith PA, Cole NC Oesophageal stent insertion for palliation of dysphagia in a district general hospital: experience from a case series of 137 patients. QJM. 2008 ; 101: 545-548.
21. Homs MY, Steyerberg EW, Kuipers EJ, et al. Causes and treatment of recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma. Endoscopy. 2004 ; 36: 880-886.
22. Ko HK, Song HY, Shin JH, Lee GH, Jung HY, Park SI Fate of migrated esophageal and gastroduodenal stents: experience in 70 patients. J Vasc Interv Radiol. 2007 ; 18: 725-732.
23. Szegedi L., Gal I., Kosa I., Kiss GG Palliative treatment of esophageal carcinoma with self-expanding plastic stents: a report on 69 cases. Eur J Gastroenterol Hepatol. 2006 ; 18: 1197-1201.
24. Siersema PD, Schrauwen SL, van Blankenstein M., et al. Self-expanding metal stents for complicated and recurrent esophagogastric cancer. Gastrointest Endosc. 2001 ; 54: 579-586.
25. Bower M., Jones W., Vessels B., Scoggins C., Martin R. Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy. Ann Surg Oncol. 2009 ; 16: 3161-3168.
26. Dallal HJ, Smith GD, Grieve DC, Ghosh S., Penman ID, Palmer KR A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc. 2001 ; 54: 549-557.
27. Homs MY, Steyerberg EW, Eijkenboom WM, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet. 2004 ; 364: 1497-1504.
28. Steyerberg EW, Homs MY, Stokvis A., Essink-Bot ML, Siersema PD Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection. Gastrointest Endosc. 2005 ; 62: 333-340.
29. Shenfine J., McNamee P., Steen N., Bond J., Griffin SM A randomized controlled clinical trial of palliative therapies for patients with inoperable esophageal cancer. Am J Gastroenterol. 2009 ; 104: 1674-1685.
30. Mosca F., Consoli A., Stracqualursi A., Persi A., Portale TR Comparative retrospective study on the use of plastic prostheses and self-expanding metal stents in the palliative treatment of malignant strictures of the esophagus and cardia. Dis Esophagus. 2003 ; 16: 119-125.
31. Bozzetti F., Cozzaglio L., Gavazzi C., et al. Nutritional support in patients with cancer of the esophagus: impact on nutritional status, patient compliance to therapy, and survival. Tumori. 1998 ; 84: 681-686.
32. Koea JB, Shaw JH The effect of tumor bulk on the metabolic response to cancer. Ann Surg. 1992 ; 215: 282-288.
33. Saito T., Kuwahara A., Shigemitsu Y., et al. Factors related to malnutrition in patients with esophageal cancer. Nutrition. 1991 ; 7: 117-121.
34. Siddiqui AA, Glynn C., Loren D., Kowalski T. Self-expanding plastic esophageal stents versus jejunostomy tubes for the maintenance of nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer: a retrospective study. Dis Esophagus. 2009 ; 22: 216-222.
35. Detsky AS, McLaughlin JR, Baker JP, et al. What is subjective global assessment of nutritional status ? JPEN J Parenter Enteral Nutr. 1987 ; 11: 8-13.
36. Paccagnella A., Morello M., Da Mosto MC, et al. Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy [published online ahead of print August 30, 2009]. Support Care Cancer.
37. Daly JM, Weintraub FN, Shou J., Rosato EF, Lucia M. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg. 1995 ; 221: 327-338.
38. Marin Caro M., Laviano A., Pichard C. Nutritional intervention and quality of life in adult oncology patients. Clin Nutr. 2007 ; 26: 289-301. (Pubitemid 46760478)
39. Ravasco P., Monteiro-Grillo I., Vidal PM, Camilo ME Cancer: disease and nutrition are key determinants of patients quality of life. Support Care Cancer. 2004 ; 12: 246-252.
40. Lecleire S., Di Fiore F., Antonietti M., et al. Undernutrition is predictive of early mortality after palliative self-expanding metal stent insertion in patients with inoperable or recurrent esophageal cancer. Gastrointest Endosc. 2006 ; 64: 479-484.
41. McCann RM, Hall WJ, Groth-Juncker A. Comfort care for terminally ill patients: the appropriate use of nutrition and hydration. JAMA. 1994 ; 272: 1263-1266.
42. Bachmann P., Marti-Massoud C., Blanc-Vincent MP, et al. Summary version of the Standards, Options and Recommendations for palliative or terminal nutrition in adults with progressive cancer (2001). Br J Cancer. 2003 ; 89 (suppl 1). S107 - S110.
43. Ravasco P., Monteiro Grillo I., Camilo M. Cancer wasting and quality of life react to early individualized nutritional counselling! Clin Nutr. 2007 ; 26: 7-15.
44. Colomer R., Moreno-Nogueira JM, Garcia-Luna PP, et al. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr. 2007 ; 97: 823-831.
45. Read JA, Beale PJ, Volker DH, Smith N., Childs A., Clarke SJ Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer: effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer. 2007 ; 15: 301-307.
46. Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KC The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer. 1999 ; 81: 80-86.
47. Odelli C., Burgess D., Bateman L., et al. Nutrition support improves patient outcomes, treatment tolerance and admission characteristics in oesophageal cancer. Clin Oncol (R Coll Radiol). 2005 ; 17: 639-645.
48. Conigliaro R., Battaglia G., Repici A., et al. Polyflex stents for malignant oesophageal and oesophagogastric stricture: a prospective, multicentric study. Eur J Gastroenterol Hepatol. 2007 ; 19: 195-203.
49. Siddiqui AA, Loren D., Dudnick R., Kowalski T. Expandable polyester silicon-covered stent for malignant esophageal strictures before neoadjuvant chemoradiation: a pilot study. Dig Dis Sci. 2007 ; 52: 823-829.
50. Ott C., Ratiu N., Endlicher E., et al. Self-expanding Polyflex plastic stents in esophageal disease: various indications, complications, and outcomes. Surg Endosc. 2007 ; 21: 889-896.